Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $53,873 | 19 | 98.2% |
| Travel and Lodging | $681.45 | 5 | 1.2% |
| Food and Beverage | $330.74 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $51,325 | 31 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $3,560 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,463 | 2 | Merck Sharp & Dohme LLC ($4,463) |
| 2023 | $2,975 | 2 | Merck Sharp & Dohme LLC ($2,975) |
| 2022 | $3,825 | 2 | Merck Sharp & Dohme LLC ($3,825) |
| 2021 | $6,588 | 4 | Merck Sharp & Dohme Corporation ($6,588) |
| 2020 | $4,038 | 3 | Merck Sharp & Dohme Corporation ($4,038) |
| 2019 | $19,716 | 6 | Merck Sharp & Dohme Corporation ($19,716) |
| 2018 | $2,758 | 4 | Merck Sharp & Dohme Corporation ($2,758) |
| 2017 | $10,523 | 9 | Merck Sharp & Dohme Corporation ($6,963) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,912.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/06/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/05/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/10/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2021 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/06/2021 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,487.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/24/2021 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/27/2021 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/05/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/12/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $637.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/10/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/03/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $4,250.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/03/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $40.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/22/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $49.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/22/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $15,300.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $53.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/14/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $49.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/14/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $49.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/14/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/02/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2017 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Consulting Fee | Cash or cash equivalent | $3,625.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2017 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $74.89 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 38 | $6,114 | $3,417 |
| 2022 | 2 | 36 | 48 | $6,976 | $4,468 |
| 2021 | 1 | 17 | 28 | $3,360 | $2,152 |
| 2020 | 1 | 20 | 20 | $2,382 | $1,271 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 22 | $4,116 | $2,314 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 16 | $1,998 | $1,104 | 55.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 22 | $3,817 | $2,544 | 66.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 26 | $3,159 | $1,923 | 60.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 28 | $3,360 | $2,152 | 64.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 20 | $2,382 | $1,271 | 53.3% |
About Dr. William Herman, MD
Dr. William Herman, MD is a Internal Medicine healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316020233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Herman, MD has received a total of $54,885 in payments from pharmaceutical and medical device companies, with $4,463 received in 2024. These payments were reported across 32 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($53,873).
As a Medicare-enrolled provider, Herman has provided services to 107 Medicare beneficiaries, totaling 134 services with total Medicare billing of $11,307. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Ann Arbor, MI
- Active Since 10/23/2006
- Last Updated 05/21/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316020233
Products in Payments
- STEGLATRO (Drug) $51,325
- INVOKANA (Drug) $3,560
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ann Arbor
Dr. Marschall Runge, Md, MD
Internal Medicine — Payments: $2.3M
Terry Smith, M.d, M.D
Internal Medicine — Payments: $2.1M
Harry Erba, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Dinesh Khanna, M.d, M.D
Internal Medicine — Payments: $1.2M
Alexander Yevzlin, Md, MD
Internal Medicine — Payments: $1.2M
Vallerie Mclaughlin, Md, MD
Internal Medicine — Payments: $1.1M